Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New approach aims to prevent suicide in black teens

NCT ID NCT06941311

Symptom relief Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a combination of two approaches for Black teenagers who came to the emergency room with suicidal thoughts or behaviors. The first is a type of talk therapy called Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP), and the second is a support team made up of caring adults chosen by the teen. The goal was to see if this combined approach is acceptable and practical to use in a community mental health setting. Six teens participated in this initial open trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) plus a Youth-Nominated Support Team (eYST)
What this could lead to
If this approach works, it could offer a practical way to reduce suicide risk in Black adolescents by combining therapy with support from trusted adults.
What could go wrong
This was a very small, early-stage study with only 6 participants, so results may not apply to everyone. It focused on feasibility, not on proving the therapy reduces suicide attempts.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

26 people

The number who actually took part.

Started

May 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for youth: * Patients of any gender between the ages of 12 and 17 years * Patients that are able to provide at least one verifiable contact for emergency or tracking purposes * Eligible for care at MiSide * Present to the ED with suicide risk (per protocol) * Self-identify as Black (obtain from face sheet collected in triage) * Willing and able to complete enrollment procedures * Willing and able to provide signed and dated informed assent Exclusion criteria for youth: * Unable to be consented in English * Do not have a parent/legal guardian available to provide consent * Are not able to provide informed assent or to participate in the assessment due to significant agitation, psychosis, cognitive impairment, learning disability, or medical trauma * Actively engaged in specialty mental health treatment Parent/Guardian Inclusion Criteria: * Adults 18 years old and older * The parent or legal guardian of a youth participating in Aim 2 * Understand written and spoken English * Willing and able to complete enrollment procedures * Willing and able to provide signed and dated informed consent Parent/Guardian Exclusion Criteria: \- Do not understand written and spoken English Support Person Inclusion Criteria: * Adults 18 years and older * Understand written and spoken English * Approved to serve as a support person by the parent/legal guardian Support Person Exclusion Criteria: * Do not understand written and spoken English * Not approved to serve as a support person by the parent/guardian

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicide prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Suicide prevention

Contacts and locations

Locations

  • Children's Hospital of Michigan (CHM) Emergency Department

    Detroit, Michigan, 48201, United States

  • MiSide

    Detroit, Michigan, 48210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.